1
/
of
1
Retatrutide 30mg/40mg/50mg Pen.
Retatrutide 30mg/40mg/50mg Pen.
Regular price
R 2,400.00 ZAR
Regular price
Sale price
R 2,400.00 ZAR
Taxes included.
Quantity
Couldn't load pickup availability
GLP-1, GIP, and glucagon—to simultaneously suppress appetite, improve insulin sensitivity, and boost the body's energy expenditure and fat-burning.
Known as a "triple agonist," it acts on three key metabolic receptors—GLP-1, GIP, and glucagon—to suppress appetite, regulate blood sugar, and increase calorie burn. Clinical trials show unprecedented weight loss, approaching the results of bariatric surgery.
How It Works
Retatrutide goes a step further than current medications like semaglutide (Wegovy/Ozempic) and tirzepatide (Mounjaro/Zepbound) by targeting an entirely new pathway.
- GLP-1: Reduces appetite, slows digestion, and promotes fullness.
- GIP: Improves insulin secretion and helps the body manage nutrients.
- Glucagon: Stimulates fat breakdown and increases the body's energy expenditure (calorie burning).
Clinical Trial Results
In clinical studies, retatrutide has demonstrated remarkable efficacy for both weight management and metabolic health:
- Weight Loss: Phase 2 and Phase 3 trials showed participants lost an average of 24% to nearly 30% of their starting body weight over the course of the studies.
- Type 2 Diabetes: The drug significantly lowered HbA1c levels, with many participants achieving numbers associated with diabetes remission.
- Additional Benefits: Trials are also investigating its effectiveness against conditions like fatty liver disease (MASH), obstructive sleep apnea, and knee osteoarthritis
Share
